India's drug regulator identifies 135 drugs as 'not of standard quality' in December, including popular medications.
Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, ...
Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...
In May 2024, Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited (formerly Cadila Healthcare ... to market and sell pharmaceutical products in India, Bayer will now take full ...
Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS ...
Some of its pharma clients, include Aurobindo Pharma, Cadila Pharmaceutical, Granules India Ltd, Macleods Pharmaceuticals, Piramal Pharma, and Suven Pharmaceuticals. (Disclaimer: The above article ...
The objects are manufacture of drugs and pharmaceuticals, industrial chemicals, detergents, toiletries, electronics, engineering products ... The Ahmedabad-based Cadila Healthcare of the Zydus ...
In contrast to peptides, where several LAI medicinal products have been successfully ... He has worked with Zydus Cadila, Cadila Pharma, Panacea Biotech, and Ipca Labs in different capacities.
Anand Rathi Research in its IPO note said Standard Glass Lining is specialised engineering equipment manufacturers for pharma and chemical sectors in India with products across entire ... include ...
Anand Rathi Research in its IPO note said Standard Glass Lining is specialised engineering equipment manufacturers for pharma and chemical sectors in India with products across entire ... include ...
New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...
Its pharma clients include Aurobindo Pharma, Cadila Pharmaceutical, Granules India Ltd, Macleods Pharmaceuticals, Piramal Pharma, and Suven Pharmaceuticals. IIFL Capital Services Ltd (formerly ...